Investors might want to bet on Quest Diagnostics (DGX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

Introduction A key aspect driving the growth of the global drug of abuse testing services market is the rising implementation of drug testing p ...

Two-time cancer survivor, Sonya Engle, urges proactive cancer screenings, emphasizing that delaying can be detrimental.